STOCK TITAN

Centessa Pharmaceuticals Plc (CNTA) Net Income by Year

CNTA

Centessa Pharmaceuticals Plc reported a net loss of $197.5M in fiscal year 2025. This represents an increase of 16.2% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Centessa Pharmaceuticals Plc has filed alongside them.

FY2025 annual
Net Income -$197.5M
YoY +16.2%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CNTA Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Net Income-$197.5M+16.2%-$235.8M-56.0%-$151.1M+30.1%-$216.2M+43.3%-$381.1M-3473.8%-$10.7M-110.7%-$5.1M

CNTA Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Net Income-$79.2M-203.2%N/A-$54.9M-29.0%-$50.3M-14.9%-$26.1M+31.3%N/A-$42.6M-10.1%-$43.8M-76.1%-$38.0M+25.0%N/A-$38.6M+28.3%-$24.9M+61.5%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Centessa Pharmaceuticals Plc financials

Frequently Asked Questions

What was Centessa Pharmaceuticals Plc's net income in fiscal year 2025?

Centessa Pharmaceuticals Plc reported a net loss of $197.5M in fiscal year 2025.

How fast is Centessa Pharmaceuticals Plc's net income growing?

Centessa Pharmaceuticals Plc (CNTA) net income rose by 16.2% year over year, from -$235.8M to -$197.5M in fiscal year 2025.

How has Centessa Pharmaceuticals Plc's net income changed over the years?

Across the 7 fiscal years this page covers, Centessa Pharmaceuticals Plc (CNTA) net income went from -$5.1M in fiscal year 2019 to -$197.5M in fiscal year 2025.

Centessa Pharmaceuticals Plc (CNTA) reported -$79.2M in net income in Q1 2026. This represents a decrease of 203.2% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Centessa Pharmaceuticals Plc (CNTA) reported on that line in every period on record.